Your browser doesn't support javascript.
loading
Postoperative Outcomes of Total Femur Replacement in Oncologic and Nononcologic Patients: A Systematic Review of the Literature.
Gonzalez, Marcos R; Inchaustegui, Maria L; Layme, Josue; Ruiz-Arellanos, Kim; Larios, Felipe; Pretell-Mazzini, Juan.
Afiliação
  • Gonzalez MR; Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Inchaustegui ML; Department of Orthopaedics and Traumatology, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Layme J; Department of Orthopaedics and Traumatology, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Ruiz-Arellanos K; Department of Orthopaedics and Traumatology, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Larios F; Department of Orthopaedics and Traumatology, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Pretell-Mazzini J; Division of Orthopedic Oncology, Miami Cancer Institute, Baptist Health System South Florida, Plantation, Florida.
J Arthroplasty ; 2023 Dec 06.
Article em En | MEDLINE | ID: mdl-38061400
BACKGROUND: Total femur replacement (TFR) is used for primary reconstruction after extensive tumor resection or as a revision surgery due to prosthetic failure. Studies on TFR rates of failure and functional outcomes are scarce. The purpose of our study was to compare the modes of failure, amputation rates, and functional outcomes after TFR between oncologic and nononcologic patients. METHODS: We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were for this manuscript. Our study was registered on PROSPERO (413582). Quality assessment of all studies was performed using Strengthening the Reporting of Observational Studies in Epidemiology checklist. Endoprosthesis failure was assessed using the Henderson classification and functional outcomes using the Musculoskeletal Tumor Society score. Weighted means and standard deviations were calculated. RESULTS: Overall failure rate was similar between groups. Henderson type 4 failures were more common within the nononcologic group, while the others were more frequently found in the oncologic group. Overall amputation rate was higher in the oncologic group mainly due to type 5 failure. Amputations occurred mainly after type 4 and type 5 failures. Functional outcome was better within the oncologic group (70.5 versus 61.7, respectively; P < .001). CONCLUSIONS: Total femoral replacement in the oncologic and nononcologic group is associated with a high rate of failure (31% and 32.5%, respectively). Overall amputation rate was higher in the oncologic group mainly due to type 5 failure. Functional outcome was better within the oncologic group. LEVEL OF EVIDENCE: Level III.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article